Results 151 to 160 of about 197,670 (242)

Esmolol in persistent ventricular fibrillation/tachycardia with de-emphasised adrenaline - Introducing the REVIVE project. [PDF]

Resusc Plus
Gleeson-Hammerton T, Hannah J, Pike J, Taylor M, Raitt J, Owen P, Sidebottom DB, Watson A, Jeffery D, Plumb J.   +9 more
europepmc   +1 more source

Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation

ESC Heart Failure, EarlyView.
Abstract Aims Functional tricuspid regurgitation (FTR) associated with degenerative mitral regurgitation (DMR) accentuates the severity of heart failure and is a marker of poor prognosis. Little is known about FTR associated with asymptomatic DMR. Methods and results The study included 1249 asymptomatic patients with moderate or severe DMR from the ...
Christophe Tribouilloy, Yohann Bohbot, Benjamin Essayagh, Giovanni Benfari, Jeroen J. Bax, Thierry Le Tourneau, Yan Topilsky, Clemence Antoine, Dan Rusinaru, Francesco Grigioni, Nina Ajmone Marsan, Aniek van Wijngaarden, Aviram Hochstadt, Jean Christian Roussel, Prabin Thapa, Michelena Hector I, Maurice Enriquez‐Sarano   +16 more
wiley   +1 more source

A quest to unravel idiopathic ventricular fibrillation. [PDF]

Neth Heart J
de Groot JR.
europepmc   +1 more source

T1 mapping and major cardiovascular events in non‐ischaemic dilated cardiomyopathy: a systematic review and meta‐analysis

ESC Heart Failure, EarlyView.
In NIDCM patients, native T1 mapping and ECV were associated with increased risk of the composite primary endpoint of MACE and the secondary endpoint of heart failure and arrhythmic‐related events. Patients who experienced MACE had higher values of both T1 mapping and ECV.
Federico Marchini, Beatrice Dal Passo, Gianluca Campo, Elisabetta Tonet, Matteo Serenelli, Alberto Cossu, Serena Chiarello, Maria Lo Monaco, Erika Bertella, Rita Pavasini   +9 more
wiley   +1 more source

Risk stratification of elderly patients with Brugada syndrome: Results from a large Japanese cohort of idiopathic ventricular fibrillation. [PDF]

J Arrhythm
Shinohara T, Takagi M, Kamakura T, Komatsu Y, Aizawa Y, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M, Aonuma K, Japan Idiopathic Ventricular Fibrillation Study (J‐IVFS) Investigators.   +10 more
europepmc   +1 more source

Prescription of guideline‐directed medical therapy in heart failure: impact on mortality and readmission

ESC Heart Failure, EarlyView.
Routine data analysis showing a better outcome regarding mortality and readmission in HF patients when being prescribed the current four‐drug treatment (vs. the outdated two‐drug therapy) 91–365 days after index hospital stay. Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy ...
Martin Möckel, Samipa Pudasaini, Kristina Feldmann, Henning Thomas Baberg, Benny Levenson, Jürgen Malzahn, Thomas Mansky, Guido Michels, Christian Günster, Elke Jeschke   +9 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Complexities of Management of Atypical Ventricular Fibrillation Storm in a Young Patient With TANGO2. [PDF]

Case Rep Pediatr
Gonzalez Corcia MC, Bradshaw C, Chronopoulou E, Shortland J, O'Sullivan B, Murphy T.   +5 more
europepmc   +1 more source

Ventricular Response to Atrial Fibrillation [PDF]

Journal of the American College of Cardiology, 1984
openaire   +2 more sources

Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation

ESC Heart Failure, EarlyView.
In the context of patients with severe heart failure, it is crucial to ensure adequate preconditioning before considering the implantation of dLVAD. Although several types of mechanical circulatory assist devices are available and all offer a significant advantage, the present study suggests that the higher the flow rate provided by the Impella®, the ...
Marta L. Medina, Daniel Lewin, Hendrik Treede, Sebastian V. Rojas, Alexander Bernhardt, Michael Billion, Anna L. Meyer, Ivan Netuka, Janajade Kooij, Marina Pieri, Antonio Loforte, Mauro Rinaldi, Mariusz K. Szymanski, Adriaan O. Kraajieveld, Christian J.H. Moeller, Payam Akhyari, Khalil Jawad, Bastian Schmack, Gloria Färber, Assad Haneya, Daniel Zimpfer, Gaik Nersesian, Ilija Djordjevic, Diyar Saeed, Finn Gustafsson, Anna M. Scandroglio, Bart Meyns, Steffen Hofmann, Jan Belohlavek, Jan Gummert, Pia Lanmueller, Evgenij V. Potapov, Mehmet Oezkur   +32 more
wiley   +1 more source